Literature DB >> 24362933

Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection.

Peter Liehl1, Vanessa Zuzarte-Luís1, Jennie Chan2, Thomas Zillinger3, Fernanda Baptista1, Daniel Carapau1, Madlen Konert1, Kirsten K Hanson1, Céline Carret1, Caroline Lassnig4, Mathias Müller4, Ulrich Kalinke5, Mohsan Saeed6, Angelo Ferreira Chora1, Douglas T Golenbock7, Birgit Strobl4, Miguel Prudêncio1, Luis P Coelho1, Stefan H Kappe8, Giulio Superti-Furga9, Andreas Pichlmair9, Ana M Vigário10, Charles M Rice6, Katherine A Fitzgerald7, Winfried Barchet11, Maria M Mota1.   

Abstract

Before they infect red blood cells and cause malaria, Plasmodium parasites undergo an obligate and clinically silent expansion phase in the liver that is supposedly undetected by the host. Here, we demonstrate the engagement of a type I interferon (IFN) response during Plasmodium replication in the liver. We identified Plasmodium RNA as a previously unrecognized pathogen-associated molecular pattern (PAMP) capable of activating a type I IFN response via the cytosolic pattern recognition receptor Mda5. This response, initiated by liver-resident cells through the adaptor molecule for cytosolic RNA sensors, Mavs, and the transcription factors Irf3 and Irf7, is propagated by hepatocytes in an interferon-α/β receptor-dependent manner. This signaling pathway is critical for immune cell-mediated host resistance to liver-stage Plasmodium infection, which we find can be primed with other PAMPs, including hepatitis C virus RNA. Together, our results show that the liver has sensor mechanisms for Plasmodium that mediate a functional antiparasite response driven by type I IFN.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24362933      PMCID: PMC4096771          DOI: 10.1038/nm.3424

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  51 in total

Review 1.  The silent path to thousands of merozoites: the Plasmodium liver stage.

Authors:  Miguel Prudêncio; Ana Rodriguez; Maria M Mota
Journal:  Nat Rev Microbiol       Date:  2006-11       Impact factor: 60.633

2.  Using GOstats to test gene lists for GO term association.

Authors:  S Falcon; R Gentleman
Journal:  Bioinformatics       Date:  2006-11-10       Impact factor: 6.937

3.  Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia.

Authors:  Elisabeth Kamphuis; Tobias Junt; Zoe Waibler; Reinhold Forster; Ulrich Kalinke
Journal:  Blood       Date:  2006-07-25       Impact factor: 22.113

4.  Effective and cheap removal of leukocytes and platelets from Plasmodium vivax infected blood.

Authors:  Kanlaya Sriprawat; Supaporn Kaewpongsri; Rossarin Suwanarusk; Mara L Leimanis; Usa Lek-Uthai; Aung Pyae Phyo; Georges Snounou; Bruce Russell; Laurent Renia; François Nosten
Journal:  Malar J       Date:  2009-06-02       Impact factor: 2.979

5.  Genome-wide discovery and verification of novel structured RNAs in Plasmodium falciparum.

Authors:  Tobias Mourier; Celine Carret; Sue Kyes; Zoe Christodoulou; Paul P Gardner; Daniel C Jeffares; Robert Pinches; Bart Barrell; Matt Berriman; Sam Griffiths-Jones; Alasdair Ivens; Chris Newbold; Arnab Pain
Journal:  Genome Res       Date:  2007-12-20       Impact factor: 9.043

6.  Heme oxygenase-1 is an anti-inflammatory host factor that promotes murine plasmodium liver infection.

Authors:  Sabrina Epiphanio; Sebastian A Mikolajczak; Lígia A Gonçalves; Ana Pamplona; Silvia Portugal; Sónia Albuquerque; Michael Goldberg; Sofia Rebelo; Daniel G Anderson; Akin Akinc; Hans-Peter Vornlocher; Stefan H I Kappe; Miguel P Soares; Maria M Mota
Journal:  Cell Host Microbe       Date:  2008-05-15       Impact factor: 21.023

Review 7.  Cerebral malaria and the hemolysis/methemoglobin/heme hypothesis: shedding new light on an old disease.

Authors:  Ana Pamplona; Thomas Hanscheid; Sabrina Epiphanio; Maria M Mota; Ana M Vigário
Journal:  Int J Biochem Cell Biol       Date:  2008-09-27       Impact factor: 5.085

8.  Improved isolation of murine hepatocytes for in vitro malaria liver stage studies.

Authors:  Lígia A Gonçalves; Ana M Vigário; Carlos Penha-Gonçalves
Journal:  Malar J       Date:  2007-12-20       Impact factor: 2.979

9.  The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis.

Authors:  Zachary J Roberts; Nadege Goutagny; Pin-Yu Perera; Hiroki Kato; Himanshu Kumar; Taro Kawai; Shizuo Akira; Ram Savan; David van Echo; Katherine A Fitzgerald; Howard A Young; Lai-Ming Ching; Stefanie N Vogel
Journal:  J Exp Med       Date:  2007-06-11       Impact factor: 14.307

Review 10.  Interferon-inducible antiviral effectors.

Authors:  Anthony J Sadler; Bryan R G Williams
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

View more
  128 in total

1.  Hepatocytes break the silence during liver-stage malaria.

Authors:  Ashraful Haque; Christian Engwerda
Journal:  Nat Med       Date:  2014-01       Impact factor: 53.440

2.  The E3 ubiquitin ligase MARCH1 regulates antimalaria immunity through interferon signaling and T cell activation.

Authors:  Jian Wu; Lu Xia; Xiangyu Yao; Xiao Yu; Keyla C Tumas; Wenxiang Sun; Yang Cheng; Xiao He; Yu-Chih Peng; Brajesh K Singh; Cui Zhang; Chen-Feng Qi; Silvia Bolland; Sonja M Best; Channe Gowda; Ruili Huang; Timothy G Myers; Carole A Long; Rong-Fu Wang; Xin-Zhuan Su
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-30       Impact factor: 11.205

3.  CD40 is required for protective immunity against liver stage Plasmodium infection.

Authors:  Sara A Murray; Isaac Mohar; Jessica L Miller; Katherine J Brempelis; Ashley M Vaughan; Stefan H I Kappe; Ian N Crispe
Journal:  J Immunol       Date:  2015-02-02       Impact factor: 5.422

Review 4.  Unveiling the pathogen behind the vacuole.

Authors:  Peter Liehl; Vanessa Zuzarte-Luis; Maria M Mota
Journal:  Nat Rev Microbiol       Date:  2015-07-20       Impact factor: 60.633

5.  Host ER stress during malaria parasite infection.

Authors:  Alexis Kaushansky; Stefan H I Kappe
Journal:  EMBO Rep       Date:  2015-07-02       Impact factor: 8.807

6.  Alterations in Phosphorylation of Hepatocyte Ribosomal Protein S6 Control Plasmodium Liver Stage Infection.

Authors:  Elizabeth K K Glennon; Laura S Austin; Nadia Arang; Heather S Kain; Fred D Mast; Kamalakannan Vijayan; John D Aitchison; Stefan H I Kappe; Alexis Kaushansky
Journal:  Cell Rep       Date:  2019-03-19       Impact factor: 9.423

7.  Targeting liver stage malaria with metformin.

Authors:  Iset Medina Vera; Margarida T Grilo Ruivo; Leonardo F Lemos Rocha; Sofia Marques; Sangeeta N Bhatia; Maria M Mota; Liliana Mancio-Silva
Journal:  JCI Insight       Date:  2019-12-19

8.  Type I Interferon Responses Drive Intrahepatic T cells to Promote Metabolic Syndrome.

Authors:  Magar Ghazarian; Xavier S Revelo; Mark K Nøhr; Helen Luck; Kejing Zeng; Helena Lei; Sue Tsai; Stephanie A Schroer; Yoo Jin Park; Melissa Hui Yen Chng; Lei Shen; June Ann D'Angelo; Peter Horton; William C Chapman; Diane Brockmeier; Minna Woo; Edgar G Engleman; Oyedele Adeyi; Naoto Hirano; Tianru Jin; Adam J Gehring; Shawn Winer; Daniel A Winer
Journal:  Sci Immunol       Date:  2017-04-21

Review 9.  Effects of type I interferons in malaria.

Authors:  Ismail Sebina; Ashraful Haque
Journal:  Immunology       Date:  2018-07-05       Impact factor: 7.397

Review 10.  A bite to fight: front-line innate immune defenses against malaria parasites.

Authors:  Stephanie Tannous; Esther Ghanem
Journal:  Pathog Glob Health       Date:  2018-01-29       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.